FDA Adverse Event Injury Summary report: N

CYPHER SIROLIMUS-ELUTING CORONARY STENT

MDR report key: 1190289 · Received October 6, 2008

Report

Report Number
3003742446-2008-00189
Event Type
Injury
Date Received
October 6, 2008
Date of Event
August 23, 2005
Report Date
September 18, 2008
Manufacturer
CORDIS LLC (PR)
Product Code
NIQ
PMA / PMN Number
P020026
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE STENT WAS NOT RETURNED FOR EVALUATION; IT REMAINED IMPLANTED. A REVIEW OF THE MANUFACTURING RECORDS COULD NOT BE DONE WITHOUT A LOT NUMBER. STENT THROMBOSIS IS A POTENTIAL ADVERSE EVENT ASSOCIATED WITH CORONARY ARTERY STENTING. WITH SUCH LIMITED INFORMATION, IT IS NOT POSSIBLE TO DETERMINE WHAT FACTORS MAY HAVE CONTRIBUTED TO THIS EVENT.

Description of Event or Problem · 1

THIS PATIENT EXPERIENCED STENT THROMBOSIS LEADING TO MYOCARDIAL INFARCTION FOLLOWING CYPHER STENT IMPLANTATION IN THE RCA. AS REPORTED, CORONARY ARTERY BYPASS SURGERY IS "GUARANTEED IN THE FUTURE". NO OTHER INFORMATION HAS BEEN PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CYPHER SIROLIMUS-ELUTING CORONARY STENT DRUG-ELUTING STENT (NIQ) NIQ CORDIS LLC (PR) NA UNK

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization| L| R